Studies on cortical tissue plasminogen activator in renal disease. Part I: Studies in the glomerulonephritis
Morozumi, K.
Nihon Jinzo Gakkai Shi 24(2): 153-166
1982
ISSN/ISBN: 0385-2385 PMID: 7201539 Document Number: 193560
Document emailed within 1 workday
Related Documents
Kobayashi, Y.; Fukuo, Y.; Shibuya, T.; Terashi, A. 1990: The correlation between the activity of tissue plasminogen activator (TPA), levels of tissue plasminogen activator inhibitor (PAI-1) antigen and serum lipids in healthy subjects Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 27(5): 578-583Pietrucha, T.; Stec, W.J.; Okruszek, A.; Uznański, B.; Koziołkiewicz, M.; Wilk, A.; Płucienniczak, A.; Swiatkowska, M.; Cierniewski, C.S. 1994: The epidermal growth factor-like domain from tissue plasminogen activator. Cloning in E. coli, purification and ESR studies of its interaction with human blood platelets Acta Biochimica Polonica 41(1): 25-34
Han, X.M.; Chen, Z.Q.; Mao, H.M. 1990: Determination of plasma tissue type plasminogen activator and plasminogen activator inhibitor activity in patients with ischemic stroke Zhonghua Nei Ke Za Zhi 29(9): 544-546; 575-576
Habib, S.S.; Abdel Gader, A.G.M.; Kurdi, M.I.; Suriya, M.O.; Al Aseri, Z. 2012: Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina JPMA. Journal of the Pakistan Medical Association 62(7): 681-685
De Moerloose, P.; Mermillod, N.; Amiral, J.; Reber, G. 1998: Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1 Thrombosis and Haemostasis 79(3): 554-556
Yamada, R.; Yamada, S.; Ishii, A.; Tane, S. 1993: Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-1 in blood obtained from patients of idiopathic central serous chorioretinopathy Nippon Ganka Gakkai Zasshi 97(8): 955-960
Fukao, H.; Yamamoto, K.; Matsuo, O. 1991: Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome Rinsho Byori. Japanese Journal of Clinical Pathology 39(7): 720-726
Shiba, E.; Kobayashi, T.; Yayoi, E.; Takatsuka, Y.; Koyama, H.; Takai, S.; Mori, T. 1992: Measurement of plasminogen activator and plasminogen activator inhibitor in breast cancer tissue: preliminary report Nihon Geka Gakkai Zasshi 93(1): 109
Wallnöfer, A.E.; van Griensven, J.M.; Schoemaker, H.C.; Cohen, A.F.; Lambert, W.; Kluft, C.; Meijer, P.; Kooistra, T. 1993: Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in humans Thrombosis and Haemostasis 70(6): 1005-1008
Glas-Greenwalt, P.; Hall, J.M.; Panke, T.W.; Kant, K.S.; Allen, C.M.; Pollak, V.E. 1986: Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpura Journal of Laboratory and Clinical Medicine 108(5): 415-422
Nelles, L.; Lijnen, H.R.; Van Nuffelen, A.; Demarsin, E.; Collen, D. 1990: Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA) Thrombosis and Haemostasis 64(1): 53-60
Fujii, S.; Lucore, C.L.; Hopkins, W.E.; Billadello, J.J.; Sobel, B.E. 1990: Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells Thrombosis and Haemostasis 64(3): 412-419
Rość, D.; Drewniak, W.; Kotschy, M.; Graczykowska-Koczorowska, A.; Raukuć, D. 1997: Plasminogen tissue activator and plasminogen tissue inhibitor in type Ii diabetes Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 2(7): 24-25
Okamoto, U.; Nagamatsu, Y.; Matsumoto, M.; Yamamoto, J. 1974: Studies on a plasminogen activating system in human milk. I. Isolation of plasminogen activator and proactivator from human milk, and estimation of their molecular weights Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 37(2): 121-131
Labarrere, C.A.; Pitts, D.; Nelson, D.R.; Faulk, W.P. 1995: Coronary artery disease in cardiac allografts: association with depleted arteriolar tissue plasminogen activator Transplantation Proceedings 27(3): 1941-1943
Goldberg, S.L.; Shubert, J.; Rao, A.K.; Redei, I.; Klumpp, T.R.; Mangan, K.F. 1996: Treatment of hepatic veno-occlusive disease with low-dose tissue plasminogen activator: impact on coagulation profile Bone Marrow Transplantation 18(3): 633-636
Chen, Z.Y. 1993: A study on the circadian variation of tissue-type plasminogen activator and its rapid inhibitor in patients with coronary heart disease Zhonghua Xin Xue Guan Bing Za Zhi 21(3): 163-164; 188
Patton, D.F.; Harper, J.L.; Wooldridge, T.N.; Gordon, B.G.; Coccia, P.; Haire, W.D. 1996: Treatment of veno-occlusive disease of the liver with bolus tissue plasminogen activator and continuous infusion antithrombin III concentrate Bone Marrow Transplantation 17(3): 443-447
Virji, M.A.; Aggarwal, S.; Kang, Y. 1989: Alterations in plasminogen activator and plasminogen activator inhibitor levels during liver transplantation Transplantation Proceedings 21(3): 3540-3541
Piotrowski, Z.; Soszka, T. 1990: Tissue plasminogen activator (PA) and urokinase inhibitor in the tissue of neutral and hyperthyroid goitre Folia Haematologica 117(1): 37-43